术后阿片类初治患者的处方与过量及误用的关联:回顾性队列研究
该回顾性队列研究利用2008至2016年间37,651,619例商业保险患者的医疗与药房行政数据库,纳入1,015,116例接受手术的阿片类初治患者,评估术后阿片类处方模式与依赖、过量或滥用的关联。568,612例(56.0%)患者术后接受阿片类药物,5,906例(0.6%,每10万人年183例)被诊断编码识别为滥用。总用药时长是最强预测因子:每增加一次续方,调整后误用率增加44.0%(95%CI 40.8%至47.2%,P<0.001);每增加一周用药,调整后风险增加19.9%(95%CI 18.5%至21.4%,P<0.001)。作者认为,术后早期处方时长而非剂量与最终误用的关联更强。
要点
- 在1,015,116例阿片类初治手术患者中,568,612例(56.0%)术后接受阿片类药物,5,906例(0.6%,每10万人年183例)被识别为滥用。
- 每增加一次阿片类续方,调整后误用率增加44.0%(95%CI 40.8%至47.2%,P<0.001)。
- 每增加一周阿片类用药,调整后误用风险增加19.9%(95%CI 18.5%至21.4%,P<0.001)。
- 总用药时长是误用的最强预测因子,作者认为术后早期处方时长而非剂量与最终误用的关联更强。
适用人群与场景
- 2008至2016年间商业保险数据库中接受手术的阿片类初治患者,共1,015,116例。
研究设计与关键结果
- 回顾性队列研究,利用37,651,619例商业保险患者的关联医疗与药房行政数据库,纳入1,015,116例阿片类初治手术患者,评估术后阿片类处方模式与依赖、过量或滥用的关联。
- 568,612例(56.0%)患者术后接受阿片类药物,5,906例(0.6%,每10万人年183例)被诊断编码识别为滥用。
- 总用药时长是最强预测因子:每增加一次续方,调整后误用率增加44.0%(95%CI 40.8%至47.2%,P<0.001);每增加一周用药,调整后风险增加19.9%(95%CI 18.5%至21.4%,P<0.001)。
- 作者认为,术后早期处方时长而非剂量与最终误用的关联更强;分析量化了处方选择与阿片类误用的关联,并识别了可能产生影响的杠杆。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,术后早期阿片类处方时长而非剂量与最终误用的关联更强,识别了处方选择中可能产生影响的杠杆。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To quantify the effects of varying opioid prescribing patterns after surgery on dependence, overdose, or abuse in an opioid naive population.
DESIGN: Retrospective cohort study.
SETTING: Surgical claims from a linked medical and pharmacy administrative database of 37 651 619 commercially insured patients between 2008 and 2016.
PARTICIPANTS: 1 015 116 opioid naive patients undergoing surgery.
MAIN OUTCOME MEASURES: Use of oral opioids after discharge as defined by refills and total dosage and duration of use. The primary outcome was a composite of misuse identified by a diagnostic code for opioid dependence, abuse, or overdose.
RESULTS: 568 612 (56.0%) patients received postoperative opioids, and a code for abuse was identified for 5906 patients (0.6%, 183 per 100 000 person years). Total duration of opioid use was the strongest predictor of misuse, with each refill and additional week of opioid use associated with an adjusted increase in the rate of misuse of 44.0% (95% confidence interval 40.8% to 47.2%, P<0.001), and 19.9% increase in hazard (18.5% to 21.4%, P<0.001), respectively.
CONCLUSIONS: Each refill and week of opioid prescription is associated with a large increase in opioid misuse among opioid naive patients. The data from this study suggest that duration of the prescription rather than dosage is more strongly associated with ultimate misuse in the early postsurgical period. The analysis quantifies the association of prescribing choices on opioid misuse and identifies levers for possible impact.
参考来源
- Brat GA, Agniel D, Beam A, et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ. 2018. PMID: 29343479. doi:10.1136/bmj.j5790
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。